Frequently Asked Questions

Get answers to common questions about Semaglutide – Monthly.

Semaglutide, a GLP-1 receptor agonist, reduces appetite and slows gastric emptying. In our monthly program it's medically supervised, combined with counseling and monitoring, producing clinically significant weight loss when paired with lifestyle changes and ongoing adherence.

Each visit includes a health assessment, dose administration or adjustment, progress review, and side-effect screening. We provide nutrition guidance, behavior support, and lab monitoring as needed to ensure safety and steady progress throughout your treatment.

Common side effects include nausea, constipation, diarrhea, and occasional vomiting, typically improving over weeks. Serious reactions are rare but possible. We screen medical history, monitor labs, and adjust dosing to minimize risks—contact us promptly for concerning symptoms.

Ideal candidates are adults with overweight or obesity who haven't achieved results through diet and exercise alone. Candidates undergo medical evaluation to rule out contraindications, and must commit to follow-up visits, lifestyle changes, and monitoring for safe, effective results.

Many clients notice appetite reduction and initial weight changes within weeks, with more substantial, measurable fat loss occurring over months. Our program emphasizes consistent monthly care and lifestyle adjustments for progressive, sustainable results typically observed after three months.

Dosing begins at a low level and is gradually titrated based on tolerance, response, and health markers. Our clinicians review labs, side effects, and weight trends each month to optimize dose, balancing efficacy with minimal adverse effects.